FDAnews
www.fdanews.com/articles/148694-nascent-nymox-pharmaceutical-reports-quarterly-loss

Nascent Nymox Pharmaceutical Reports Quarterly Loss

August 14, 2012
Nymox Pharmaceutical reported a second quarter net loss of $1.7 million, or 5 cents a share, as its lead product advances into late-stage development.
New Jersey Star-Ledger